Summary:
Bloomberg says I've used up all my free articles and has put a paywall up, but you might be able to read it. At stake is not just the well-being of millions of Chinese people, but the future of the global healthcare industry. China has set its sights on creating a holy grail healthcare system that satisfies patients’ needs and control costs while still encouraging cutting-edge research—and the world is watching. Whether it succeeds will affect the future of the global industry. Bloomberg China Is Striving for the World’s Best, Cheapest Healthcare
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Bloomberg says I've used up all my free articles and has put a paywall up, but you might be able to read it.Bloomberg says I've used up all my free articles and has put a paywall up, but you might be able to read it. At stake is not just the well-being of millions of Chinese people, but the future of the global healthcare industry. China has set its sights on creating a holy grail healthcare system that satisfies patients’ needs and control costs while still encouraging cutting-edge research—and the world is watching. Whether it succeeds will affect the future of the global industry. Bloomberg China Is Striving for the World’s Best, Cheapest Healthcare
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Jeremy Smith writes UK workers’ pay over 6 years – just about keeping up with inflation (but one sector does much better…)
Robert Vienneau writes The Emergence of Triple Switching and the Rarity of Reswitching Explained
Lars Pålsson Syll writes Schuldenbremse bye bye
Robert Skidelsky writes Lord Skidelsky to ask His Majesty’s Government what is their policy with regard to the Ukraine war following the new policy of the government of the United States of America.
At stake is not just the well-being of millions of Chinese people, but the future of the global healthcare industry. China has set its sights on creating a holy grail healthcare system that satisfies patients’ needs and control costs while still encouraging cutting-edge research—and the world is watching.
Whether it succeeds will affect the future of the global industry.